These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11230084)

  • 21. Drug administration error related to computerized prescribing.
    Le Garlantezec P; Aupée O; Alméras D; Lefeuvre L; Souleau B; Sgarioto A; Bohand X
    J Oncol Pharm Pract; 2010 Dec; 16(4):273-6. PubMed ID: 19833684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature.
    Pongudom S; Chinthammitr Y
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S258-63. PubMed ID: 21721457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 24. Death due to intrathecal vindesine.
    Prescrire Int; 2008 Aug; 17(96):153. PubMed ID: 19492486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
    J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing intrathecal administration of vincristine.
    Gilbar PJ; Carrington CV
    Med J Aust; 2004 Oct; 181(8):464. PubMed ID: 15487972
    [No Abstract]   [Full Text] [Related]  

  • 27. The 2000 Burkitt lymphoma trial in Malawi.
    Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
    Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.
    Brugières L; Le Deley MC; Rosolen A; Williams D; Horibe K; Wrobel G; Mann G; Zsiros J; Uyttebroeck A; Marky I; Lamant L; Reiter A
    J Clin Oncol; 2009 Feb; 27(6):897-903. PubMed ID: 19139435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 30. Intrathecal vincristine: 3 fatal cases and a review of the literature.
    Hennipman B; de Vries E; Bökkerink JP; Ball LM; Veerman AJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):816-9. PubMed ID: 19801949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
    Boran P; Tokuc G; Boran BO; Oktem S
    Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.
    Qweider M; Gilsbach JM; Rohde V
    J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
    Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
    Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accidental intrathecal administration of vincristine.
    D'Addario A; Galuppo J; Navari C; Schultz M; Cuello N; Troncoso JC; Riudavets MA
    Am J Forensic Med Pathol; 2010 Mar; 31(1):83-4. PubMed ID: 19935391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
    J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
    Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
    Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
    Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.
    Alcaraz A; Rey C; Concha A; Medina A
    J Toxicol Clin Toxicol; 2002; 40(5):557-61. PubMed ID: 12215050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T; Costa V; Silva I; Oliva T; Norton L
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.